Tobacco Use
2
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Century TherapeuticsPHILADELPHIA, PA
3 programs2
VLN cigarettesPhase 11 trial
VLN menthol cigarettesPhase 11 trial
Non-Menthol Very Low Nicotine CigarettesN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Century TherapeuticsVLN menthol cigarettes
Century TherapeuticsVLN cigarettes
Century TherapeuticsNon-Menthol Very Low Nicotine Cigarettes
Alliance PharmaceuticalsTraining
Clinical Trials (4)
Total enrollment: 563 patients across 4 trials
Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes
Start: May 2018Est. completion: Oct 201855 patients
Phase 1Completed
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
Start: Apr 2018Est. completion: Sep 201866 patients
Phase 1Completed
A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes
Start: Jun 2018Est. completion: Mar 2019142 patients
N/ACompleted
Tobacco Treatment TrAining Network in Greece & Cyprus
Start: Feb 2017Est. completion: Dec 2019300 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space